Log in to MyACC
Professional Bio:
I am a Cardiologist/Intensive Care physician with a dedicated interest in heart failure, hemodynamics, exercise physiology and cardiorenal interactions. I have graduated as an M.D. in 2010 (KU Leuven, Belgium), obtained my Ph.D. degree in 2015 (Hospital Oost-Limburg & Hasselt University, Belgium), and received an M.Sc. in Clinical Trials in 2022 (Oxford University, UK). I am currently currently employed as Clinic Head/Clinical Professor at University Hospital Brussels/Vrije Universiteit Brussel (Belgium), where I care for patients with heart failure & cardiac devices, attend the cardiac intensive care unit, and run the exercise physiology lab. I currently serve as Board Member for the Acute Cardiovascular Care Association within the European Society of Cardiology, Deputy Editor for European Heart Journal: Acute Cardiovascular Care and Editorial Consultant for JACC: Heart Failure.
General Statement of Disclosure:
CONSULTING FEES/HONORARIA: Novartis Corporation(MODEST), Roche diagnostics(MODEST), Daiichi Sankyo(MODEST), Bristol-Myers Squibb Company (MODEST), AstraZeneca Pharmaceuticals(MODEST), Boehringer Ingelheim Pharmaceuticals, Inc(MODEST), Bayer Healthcare Pharmaceuticals(MODEST) SPEAKER'S BUREAU: Novartis Corporation(MODEST), Boehringer Ingelheim Pharmaceuticals, Inc(MODEST), Menarini Group(MODEST), Pfizer Inc(MODEST), AstraZeneca Pharmaceuticals(MODEST), Bristol-Myers Squibb Company (MODEST) RESEARCH/RESEARCH GRANTS: Roche diagnostics(SIGNIFICANT)
